Nombre del producto:(2S)-5-oxopyrrolidine-2-carboxylic acid

IUPAC Name:(2S)-5-oxopyrrolidine-2-carboxylic acid

CAS:98-79-3
Fórmula molecular:C5H7NO3
Pureza:98%
Número de catálogo:CM100584
Peso molecular:129.12

Unidad de embalaje Stock disponible Precio($) Cantidad
CM100584-500g in stock džŸŸ

Sólo para uso en I+D..

Formulario de consulta

   refresh    

Detalles del producto

Núm. De CAS :98-79-3
Fórmula molecular:C5H7NO3
Punto de fusión:-
Código de sonrisas:OC(=O)[C@@H]1CCC(=O)N1
Densidad:
Número de catálogo:CM100584
Peso molecular:129.12
Punto de ebullición:
Nº Mdl:MFCD00005272
Almacenamiento:Store at room temperature.

Category Infos

Amino Acids and Peptides
Amino acids are organic compounds containing a basic amino group and an acidic carboxyl group. Because amino acids contain both amino and carboxyl groups, they can be polymerized in an end-to-end manner, removing a molecule of water to form a covalent amide bond or peptide bond. Many amino acids are linked together end to end to form a polypeptide. Amino acids and peptides are important components in the fields of medicine and life sciences.
amino acids wholesale
if you are finding amino acids wholesaler in china, we will be your best choose! We have our own factory, so we can give you a cheap price!
Pyrrolidines
Pyrrolidine, also known as tetrahydropyrrole, is a saturated five-membered heterocyclic ring, which is miscible with water. Pyrrolidine exists in many alkaloids and drug molecules, such as kappa opioids, antagonists of dopamine D4 receptors, and HIV reverse transcriptase inhibitors.

Column Infos

Ivosidenib
Tibsovo (ivosidenib tablets) is a precision medicine that targets a specific type of mutation known as isocitrate dehydrogenase 1 (IDH1). Tibsovo is approved in five indications globally, including approvals in the U.S., European Union, Australia, and China.
Tibsovo is the first and only approved targeted therapy for R/R MDS patients with a susceptible IDH1 mutation.
Fifth approved indication for Tibsovo solidifies Servier’s leadership in mutant IDH inhibition.